as a proportion of its overall global health spending, 
squeezed by both stagnant budgets and growing 
needs. 
(13) Innovation at the United States Agency 
for International Development is primarily supported 
from siloed disease- and population-specific appro-
priations accounts, resulting in the limitation of its 
ability to seek shared value across health sectors or 
health threats. 
(14) The United States Agency for Inter-
national Development is compelled to prioritize sup-
port for immediate program needs with imperfect 
tools at the expense of support for technologies that 
can improve clinical effectiveness, increase access to 
care, save costs, and build capacity and ownership 
by partner countries. 
SEC. 3. STATEMENT OF POLICY. 
It is the policy of the United States that— 
(1) research and development for new health 
technologies is essential for the success of the global 
health programs of the United States Government, 
by providing for the improved effectiveness, cost-ef-
fectiveness, and sustainability of such programs; and 
(2) funding and other support for global health 
research and development under this Act shall be 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
additional and complementary to, and may not re-
place, displace, or otherwise compromise, funding 
otherwise provided for existing and ongoing global 
health research and development of the United 
States Government or activities relating to the im-
plementation of the global health programs of the 
United States Government. 
SEC. 4. CHIEF INNOVATION OFFICER FOR HEALTH. 
(a) ESTABLISHMENT.—There is established within 
the Bureau for Global Health of the Agency the position 
of Chief Innovation Officer for Health. Such position is 
at the level of Deputy Assistant Administrator or equiva-
lent. 
(b) APPOINTMENT.—The Administrator shall appoint 
the Chief Innovation Officer for Health from among such 
individuals as the Administrator determines have relevant 
experience within private sector industry and an expert 
understanding of health finance and of the research, devel-
opment, testing, evaluation, deployment, and implementa-
tion of new health technology. 
(c) RELATIONSHIP TO ASSISTANT ADMINISTRATOR 
FOR GLOBAL HEALTH.—The Chief Innovation Officer for 
Health shall— 
(1) serve as the principal advisor to the Assist-
ant Administrator for Global Health on global health 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
research and development necessary to meet the re-
quirements of the United States Government and 
the governments of partner countries for improving 
global health; and 
(2) report directly to the Assistant Adminis-
trator for Global Health. 
(d) DUTIES.—The Chief Innovation Officer for 
Health shall be responsible for the following: 
(1) Ensuring cross-sector, Agency-wide coopera-
tion, support, and programming for global health re-
search and development, for the purpose of increas-
ing the effectiveness of international development 
programs of the Agency and supporting the foreign 
policy and development goals of the United States 
Government. 
(2) Drawing on the expertise of other depart-
ments and agencies of the United States Govern-
ment and of nongovernmental organizations (includ-
ing affected communities and institutions in low- or 
middle-income countries, businesses, health and 
science research organizations, and institutions of 
higher education) that pursue global health-related 
research and development, to identify the most 
pressing requirements for the development of health 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
technologies to improve global health and programs 
of the Agency relating to global health. 
(3) Leveraging research and investments by 
other elements of the Agency, other departments 
and agencies of the United States Government, and 
nongovernmental 
organizations 
(including 
busi-
nesses, health and science research organizations, in-
stitutions of higher education, and governments or 
other institutions of partner countries) to support 
the research and development of new health tech-
nologies by the Chief Innovation Officer of Health. 
(4) Administering the processes for the award 
of grants, entry into partnerships, and joint estab-
lishment of other arrangements, to support global 
health research and development (including by ad-
ministering the grant program under section 7). 
(5) Serving as the Chairperson of the Global 
Health Research and Development Advisory Council 
established under section 5. 
(e) AUTHORITIES.—The Assistant Administrator for 
Global Health shall take such steps as may be necessary 
to ensure that the Chief Innovation Officer for Health has 
sufficient authority within the Bureau for Global Health 
to carry out the duties under subsection (d). 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
SEC. 5. GLOBAL HEALTH RESEARCH AND DEVELOPMENT 
ADVISORY COUNCIL. 
(a) ESTABLISHMENT.—The Administrator shall es-
tablish an advisory council to be known as the ‘‘Global 
Health Research and Development Advisory Council’’ (in 
this section referred to as the ‘‘Council’’). 
(b) MEMBERSHIP.—The Council shall be composed of 
the following: 
(1) The Chief Innovation Officer for Health of 
the Agency under section 4, who shall serve as the 
Chairperson of the Council (in this section referred 
to as the ‘‘Chairperson’’). 
(2) Not more than 8 other members appointed 
by the Administrator from among individuals— 
(A) recommended for such appointment by 
the Chairperson; and 
(B) who are scientists or other experts 
with experience in global health research and 
development through or on behalf of— 
(i) the Agency; 
(ii) any other department or agency of 
the United States Government; 
(iii) affected communities in low- or 
middle-income countries; and 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
(iv) nongovernmental organizations, 
including nonprofit organizations, busi-
nesses, and institutes of higher education. 
(c) TERMS.— 
(1) IN GENERAL.—Each member other than the 
Chairperson shall be appointed for a term of 6 
years. 
(2) VACANCIES.—Any member appointed to fill 
a vacancy occurring before the expiration of the 
term for which the predecessor of the member was 
appointed shall be appointed only for the remainder 
of that term. A vacancy in the Council shall be filled 
in the manner in which the original appointment was 
made. 
(d) COMPENSATION.— 
(1) PROHIBITION OF COMPENSATION OF FED-
ERAL
EMPLOYEES.—Except as provided in para-
graph (2), members of the Council who are full-time 
officers or employees of the United States may not 
receive additional pay, allowances, or benefits by rea-
son of their service on the Council. 
(2) TRAVEL EXPENSES.—Each member of the 
Council shall receive travel expenses, including per 
diem in lieu of subsistence, in accordance with appli-
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
cable provisions under subchapter I of chapter 57 of 
title 5, United States Code. 
(e) MEETINGS.—The Council shall meet at the call 
of the Chairperson. 
(f) DUTIES.—The Council shall be responsible for ad-
vising the Administrator regarding the priorities and ob-
jectives for the Agency with respect to global health re-
search and development, including by providing such ad-
vice on an individual member basis or as a collective Coun-
cil, as the Chairperson may direct. 
(g) NONAPPLICABILITY
OF
FEDERAL
ADVISORY 
COMMITTEE ACT.—Chapter 10 of title 5, United States 
Code, shall not apply to the Council. 
SEC. 6. GLOBAL HEALTH RESEARCH AND DEVELOPMENT 
PROGRAM AREA ACTIVITIES AND BUDGET. 
(a) IN GENERAL.—The Administrator shall carry out 
global health research and development activities with re-
spect to new health technologies with the potential to ad-
vance the effectiveness and sustainability of the global 
health programs of the Agency, including the potential to 
advance— 
(1) health technologies with characteristics 
identified or otherwise prioritized by affected com-
munities and partner countries; 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
(2) health technologies with characteristics that 
facilitate introduction and access of the respective 
technology, to ensure use by those in need; and 
(3) support for capacity-building within partner 
countries and the transition by such countries to 
greater country-level ownership, responsibility, and 
decision-making with respect to global health. 
(b) BUDGET.—The Administrator shall— 
(1) not later than 90 days after the date of the 
enactment of this Act, establish a single, separate 
budget line for the activities under subsection (a), 
under which funds authorized to be appropriated or 
otherwise made available to the Administrator for 
the purpose of carrying out such activities shall be 
categorized; and 
(2) include information regarding amounts ex-
pended and requested to be expended under such 
budget line in the budget justification materials sub-
mitted in support of the budget of the President for 
any fiscal year beginning on or after the date of 
such establishment. 
SEC. 7. GRANT PROGRAM FOR EXPANDED USE OF GLOBAL 
HEALTH RESEARCH AND DEVELOPMENT. 
(a) GRANT PROGRAM.—The Administrator, acting 
through the Chief Innovation Officer for Health under sec-
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
tion 4, shall carry out a grant program under which the 
Administrator may award grants on a competitive basis 
to nongovernmental organizations that are determined eli-
gible by the Administrator. 
(b) USE
OF AMOUNTS.—Grant amounts awarded 
under this section may only be used for the following pur-
poses: 
(1) Developing new health technologies designed 
for use in low-resource settings to improve global 
health. 
(2) Evaluating and improving the implementa-
tion, production, and scale-up of health technologies 
in low-resource settings in partner countries. 
(3) Investing in the research capacity of institu-
tions in low- and middle-income partner countries to 
lead and contribute to the development of health 
technologies. 
(c) CONDITIONS ON GRANT AWARD.—The Adminis-
trator may not award a grant to an entity under this sec-
tion unless— 
(1) the entity submits to the Administrator a 
proposal demonstrating sufficient technical stand-
ards, as determined by the Administrator, for any of 
the purposes listed in paragraphs (1) through (3) of 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
subsection (b) for which the entity intends to use 
such grant amounts; 
(2) the entity agrees, as a condition of such 
award, to report to the Administrator regarding the 
use of such grant amounts on a basis that is not less 
frequent than annually for the duration of the grant 
period; and 
(3) the Administrator certifies to the appro-
priate congressional committees that such award is 
in compliance with section 3(2) of this Act. 
(d) ADDITIONAL NATURE OF AUTHORITY.—The au-
thority to award grants under this section is in addition 
to, and not in lieu of, any other authority of the Adminis-
trator, including any such authority under part I or II 
of the Foreign Assistance Act of 1961 (22 U.S.C. 2151 
et seq.). 
SEC. 8. STRATEGY AND REPORTS. 
(a) REPORT ON PROGRESS.—Not later than 180 days 
after the date of the enactment of this Act, and prior to 
the submission of the budget justification materials in 
support of the budget of the President for the first fiscal 
year following the date of the enactment of this Act, the 
Administrator shall submit to the appropriate congres-
sional committees, and publish on a publicly available 
website of the Agency, a report that contains the following: 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS
(1) A detailed description of the status of the 
Global Health Research and Development Advisory 
Council under section 5. 
(2) Recommendations by such Global Health 
Research and Development Advisory Council. 
(3) Solicitations for grant awards under section 
7. 
(4) Comprehensive accounting of awards and 
objectives to be included within the annual report to 
Congress on the health-related research and develop-
ment strategy of the Agency required pursuant to 
the Department of State, Foreign Operations, and 
Related Programs Appropriations Act (or the report 
accompanying such appropriations bill reported by 
the Committees on Appropriations of the House or 
Representatives or Senate) for the respective fiscal 
year. 
(5) A detailed description of how the planned 
investments by the Agency in the activities under 
section 6(a) align with the multiyear strategy of the 
Agency titled ‘‘Global Health Research and Develop-
ment Strategy 2023–2028’’ and developed pursuant 
to section 7019(e) of division K of the Consolidated 
Appropriations Act, 2022 (Public Law 117–103). 
VerDate Sep 11 2014 
05:22 Nov 30, 2023
Jkt 049200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H6424.IH
H6424
SSpencer on DSK126QN23PROD with BILLS